Related Experiment Video
Updated: Aug 5, 2026

High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Levofloxacin-induced fixed drug eruption
Shruti Vihang Brahmbhatt1, Malay Jayantigiri Goswami2, Mahavir Singh Rajput3
1Pharmacology, SBKS Medical Institute and Research Centre, Waghodia, Gujarat, India.
Abstract:
Fixed drug eruption is a distinctive cutaneous adverse drug reaction characterised by the recurrence of well-demarcated lesions at the same anatomical site following re-exposure to the offending drug, with residual hyperpigmentation after resolution. Antimicrobials are common triggers, although fluoroquinolones are less frequently implicated. A man in his 30s developed multiple well-defined hyperpigmented patches involving the upper lip, upper limbs and foot within 24 hours of receiving levofloxacin for a lower respiratory tract infection. The lesions were pruritic, non-tender and recurrent at previously affected sites. Clinical findings and a clear temporal relationship supported the diagnosis of fixed drug eruption. Withdrawal of levofloxacin and symptomatic treatment resulted in gradual resolution with post-inflammatory hyperpigmentation. Causality assessment using the Naranjo scale suggested a probable association. This case highlights the importance of recognising fixed drug eruption caused by commonly prescribed antibiotics and the role of careful drug history taking and adverse drug reaction reporting.
Insights
Fixed drug eruption is a skin reaction that recurs in the same spot after taking a specific drug. This case shows levofloxacin, an antibiotic, can cause this reaction, emphasizing careful drug history and reporting.
Area of Science:
- Dermatology
- Pharmacology
- Internal Medicine
Background:
- Fixed drug eruption (FDE) is a specific type of cutaneous adverse drug reaction.
- Antimicrobials are frequent triggers, but fluoroquinolones are less commonly implicated in FDE.
- Recurrence at the same site upon re-exposure and post-inflammatory hyperpigmentation are characteristic features of FDE.
Purpose of the Study:
- To report a case of fixed drug eruption.
- To highlight levofloxacin as a potential trigger for FDE.
- To emphasize the importance of recognizing FDE and accurate adverse drug reaction reporting.
Main Methods:
- A case study of a male patient in his 30s.
- Clinical diagnosis based on lesion characteristics and temporal relationship with drug intake.
- Causality assessment using the Naranjo scale.
Main Results:
- The patient developed FDE after receiving levofloxacin for a lower respiratory tract infection.
- Lesions appeared on the upper lip, upper limbs, and foot within 24 hours.
- Withdrawal of levofloxacin led to lesion resolution and post-inflammatory hyperpigmentation.
Conclusions:
- Levofloxacin can cause fixed drug eruption.
- Recognition of FDE triggered by common antibiotics is crucial.
- Thorough drug history and adverse drug reaction reporting are essential for patient safety.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Allergic Drug Reactions
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Drug Toxicity: Dose-Dependent Reactions